Amgen Inc
NASDAQ:AMGN
Amgen Inc
Net Issuance of Debt
Amgen Inc
Net Issuance of Debt Peer Comparison
Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Amgen Inc
NASDAQ:AMGN
|
Net Issuance of Debt
$2.6B
|
CAGR 3-Years
51%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
|
Abbvie Inc
NYSE:ABBV
|
Net Issuance of Debt
$12.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
181%
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Issuance of Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Moderna Inc
NASDAQ:MRNA
|
Net Issuance of Debt
-$246m
|
CAGR 3-Years
-213%
|
CAGR 5-Years
-201%
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Issuance of Debt
-$45.7m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
4%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Issuance of Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Amgen Inc's Net Issuance of Debt?
Net Issuance of Debt
2.6B
USD
Based on the financial report for Mar 31, 2024, Amgen Inc's Net Issuance of Debt amounts to 2.6B USD.
What is Amgen Inc's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 10Y
-10%
Over the last year, the Net Issuance of Debt growth was -90%. The average annual Net Issuance of Debt growth rates for Amgen Inc have been 51% over the past three years , and -10% over the past ten years .